2022
DOI: 10.1111/1756-185x.14318
|View full text |Cite
|
Sign up to set email alerts
|

How safe and effective is the use of colchicine for the treatment of gout flares? A Cochrane Review summary with commentary

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 17 publications
0
3
0
Order By: Relevance
“…Also, low-dose colchicine was less likely to cause side effects. 6 Therefore, using colchicine in low doses is generally more The patient in this case used 1 mg/day of colchicine for 6 weeks. However, after the acute attack is resolved, the dose could be reduced to 0.5 mg/day for prophylaxis.…”
Section: A Case Report Of Colchicine Toxicity Progressing From Diarrh...mentioning
confidence: 99%
“…Also, low-dose colchicine was less likely to cause side effects. 6 Therefore, using colchicine in low doses is generally more The patient in this case used 1 mg/day of colchicine for 6 weeks. However, after the acute attack is resolved, the dose could be reduced to 0.5 mg/day for prophylaxis.…”
Section: A Case Report Of Colchicine Toxicity Progressing From Diarrh...mentioning
confidence: 99%
“…13 Notably, a recent Cochrane review and its commentary concluded that there might be little or no evidence of important differences in treatment response between a high-and low-dose regimen, but the high-dose regimen clearly had a higher frequency of adverse events. 14,15 It is interesting that although acute CPP arthritis is very common in clinical practice, studies on the use of colchicine for it have been very limited, and most of them used the intravenous route 16,17 ; with oral colchicine recommendations usually following gout treatment. [18][19][20] This study aimed to compare the clinical efficacy and side effects between non-loading and loading low-dose colchicine in patients with acute crystal-associated arthritis.…”
Section: Introductionmentioning
confidence: 99%
“…The Thai Rheumatism Association recommends that colchicine should be given at 0.6 mg twice to four times daily for acute gouty arthritis 13 . Notably, a recent Cochrane review and its commentary concluded that there might be little or no evidence of important differences in treatment response between a high‐ and low‐dose regimen, but the high‐dose regimen clearly had a higher frequency of adverse events 14,15 …”
Section: Introductionmentioning
confidence: 99%